- Trials with a EudraCT protocol (209)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
209 result(s) found for: Heart block.
Displaying page 1 of 11.
EudraCT Number: 2017-002475-26 | Sponsor Protocol Number: GD2CAR01 | Start Date*: 2017-12-22 | |||||||||||
Sponsor Name:IRCCS Ospedale Pediatrico Bambino Gesù | |||||||||||||
Full Title: Phase I/II study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric patients affected by High Risk and/or relapsed/refractory Neuroblastoma | |||||||||||||
Medical condition: High Risk and/or relapsed/refractory Neuroblastoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004178-23 | Sponsor Protocol Number: T39/2021 | Start Date*: 2021-04-14 | ||||||||||||||||
Sponsor Name:Turku University Hospital | ||||||||||||||||||
Full Title: Ultrasound Guided Repeated Bilateral Transversus Thoracis Muscle Plane Block (TTP) via catheter and postoperative pain in Cardiac Surgery | ||||||||||||||||||
Medical condition: cardiac disease necessitating surgery with sternotomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000299-25 | Sponsor Protocol Number: 1.4 | Start Date*: 2014-12-05 |
Sponsor Name:Unfallkrankenhaus Salzburg | ||
Full Title: Dexmedetomidine for saphenous nerve blockade in patients undergoing anterior cruciate ligament replacement: a randomized, placebo-controlled, triple blinded study | ||
Medical condition: Dexmedetomidine -a selective alpha-2-receptor agonist- added to a local anaesthetic (ropivacaine) should prolong a saphenous block and the patients demand for the first analgesic. We designed a pro... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002519-40 | Sponsor Protocol Number: CHL.2/01-2014/M | Start Date*: 2015-08-17 | |||||||||||
Sponsor Name:Sintetica S.A. | |||||||||||||
Full Title: A prospective, randomised, non-inferiority study of Chloroprocaine 2% and the active control Ropivacaine 0.75% (AstraZeneca) in ultrasound-guided axillary nerve block for short-duration distal uppe... | |||||||||||||
Medical condition: Local anaesthesia by axillary nerve block | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001287-34 | Sponsor Protocol Number: BAY1067197/16718 | Start Date*: 2013-11-04 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A single blind, placebo controlled pilot study to explore the safety and tolerability of a single oral dose of 30 mg BAY 1067197 in patients with chronic heart failure on the background of preexist... | |||||||||||||
Medical condition: Heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004295-28 | Sponsor Protocol Number: STER-AMVR-01 | Start Date*: 2014-11-14 | |||||||||||
Sponsor Name:Oulu University Hospital, Department of Anaesthesia | |||||||||||||
Full Title: Postoperative pain management after heart valve surgery using parasternal block and PCA Oxycodone | |||||||||||||
Medical condition: Mitral or aortic valve disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000376-28 | Sponsor Protocol Number: 1245.148 | Start Date*: 2018-01-30 | |||||||||||
Sponsor Name:Boehringer Ingelheim Limited | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, mechanistic cardiac magnetic resonance study to investigate the effects of empagliflozin treatment on cardiac physiology and metabolism in patients w... | |||||||||||||
Medical condition: Chronic heart failure with reduced (HFrEF) and preserved ejection fraction (HFpEF) diagnosed at least 3 months prior to informed consent. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004504-29 | Sponsor Protocol Number: 49024 | Start Date*: 2015-02-25 |
Sponsor Name:Helse Fonna, Haugesund Sykehus | ||
Full Title: "Haemodynamic stability of bupivacaine with and without adrenaline for paracervical block during general anesthesia. A randomized controlled double blinded study." | ||
Medical condition: Cervical conisation is done for pre-cancer disease. The procedure is done with local anesthesia and general anesthesia. Local anesthesia is given by paracervical block, and several different local ... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002354-72 | Sponsor Protocol Number: 1.0 | Start Date*: 2013-09-05 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie | ||
Full Title: A QUALITATIVE ANALYSIS OF SEDATION IN INFANTS WITH CAUDAL BLOCKADE | ||
Medical condition: 34 patients aged between 0 and 3 months parted into 2 groups have to undergo caudal block. Group 1 receive a block with 1ml/kg Naropin 3.75% Group 2 receive a block with 1ml/kg Naropin 3.75% and... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-020352-59 | Sponsor Protocol Number: GHF112670 | Start Date*: 2010-07-29 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A multi-center, placebo-controlled study to evaluate the safety of GSK716155 and its effects on myocardial metabolism, myocardial function, and exercise capacity in patients with NYHA Class II/III ... | |||||||||||||
Medical condition: NYHA Class II/III congestive heart failure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004744-38 | Sponsor Protocol Number: HCA-2017-1 | Start Date*: 2018-09-11 |
Sponsor Name:Tays Sydänkeskus Oy | ||
Full Title: New truncal nerve blocks for upper torso. Part 1. Serratus anterior plane block (SAPB): Effect on pain and recovery after thoracoskopic lung surgery. Part 2. Subpectoral interfacial plane block (S... | ||
Medical condition: Osa 1 (SAPB): Suurin osa keuhkoleikkauksista tehdään keuhkon, keuhkopussin tai välikarsinan muutosten takia. Osa 2 (SIP): Avosydänkirurgiset läppäleikkaukset tehdään sydänläppien vuotojen, ahtaumi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002842-35 | Sponsor Protocol Number: 2018/07 | Start Date*: 2018-11-07 | |||||||||||
Sponsor Name:CMC Ambroise Paré | |||||||||||||
Full Title: Interest of parasternal block to prevent hypertensive and tachycardia episodes during sternotomy in patients undergoing coronary artery bypass graft | |||||||||||||
Medical condition: coronary artery bypass graft | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000202-75 | Sponsor Protocol Number: P.Sitsen.03 | Start Date*: 2007-06-15 |
Sponsor Name:Leids Universitair Medisch Centrum | ||
Full Title: A comparison of the efficacy of levobupivacaine 0,125%, ropivacaine 0,125% and ropivacaine 0,2%, all combined with sufentanil 0.5 micrograms/mL, in patient-controlled epidural analgesia after hyste... | ||
Medical condition: Primary Objective •to compare the analgesic efficacy of levobupivacaine and ropivacaine in patient-controlled epidural analgesia, as assessed by the number of requests for epidural bolus injections... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000656-18 | Sponsor Protocol Number: 2042015 | Start Date*: 2018-11-09 | |||||||||||
Sponsor Name:SINTETICA SA | |||||||||||||
Full Title: Randomized, multi-center, double-blind, two-armed, parallel active groups, prospective trial, to evaluate, in pediatric population undergoing 'Calcaneo stop' surgery or Inguinal hernia repair, the ... | |||||||||||||
Medical condition: Pediatric patients undergoing surgery of flatfoot or inguinal hernia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) ES (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001468-21 | Sponsor Protocol Number: V1.0 | Start Date*: 2015-09-24 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: Inhaled furosemide for dyspnoea relief in advanced heart failure | |||||||||||||
Medical condition: Advance heart failure - New York Class Association III-IV with ejection fraction <35%. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004672-35 | Sponsor Protocol Number: PACS2019 | Start Date*: 2020-01-10 |
Sponsor Name:Institution for Clinical Science, Karolinska Institutet | ||
Full Title: Open heart surgery – does it have to hurt that much? PACS – Parasternal After Cardiac Surgery. A prospective randomised study to assess the analgesic effect of a continuous bilateral parasternal bl... | ||
Medical condition: The analgesic effect of continuous bilateral parasternal infusion of local anaesthetic after open cardiac surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001321-17 | Sponsor Protocol Number: 11275 | Start Date*: 2016-12-02 | ||||||||||||||||||||||||||
Sponsor Name:University of Oxford | ||||||||||||||||||||||||||||
Full Title: A randomised control trial of 5-Aminolevulinic Acid in combination with Sodium Ferrous Citrate to Enhance Cardioprotection in Adults undergoing Cardiac Surgery | ||||||||||||||||||||||||||||
Medical condition: Low cardiac output states following cardioplegic arrest for cardiac surgery | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-002708-38 | Sponsor Protocol Number: 131313 | Start Date*: 2020-10-26 |
Sponsor Name:Department of Medical Science Gothenburg University | ||
Full Title: Optimized pharmacological treatment for broken heart (takotsubo) syndrome | ||
Medical condition: The medical condition is acute heart failure (Takotsubo syndrome) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001657-27 | Sponsor Protocol Number: -- | Start Date*: 2018-10-03 |
Sponsor Name: | ||
Full Title: Comparison of ultrasound guided Serratus Anterior Plane Block (SAPB) with continuous local anesthetic infusion and epidural analgesia in the treatment of multiple rib fracture analgesia: a prospect... | ||
Medical condition: Multiple traumatic rib fractures | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002699-42 | Sponsor Protocol Number: DANBLOCK | Start Date*: 2018-09-28 | |||||||||||
Sponsor Name:Bispebjerg Frederiksberg Hospital | |||||||||||||
Full Title: Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) | |||||||||||||
Medical condition: Myocardial infarction. We wish to test whether long-term treatment with betablocker (bisoprolol, carvedilol, metoprolol or nebivolol) leads to better prognosis than no treatment in patients sufferi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
